Risk of Progression to Kidney Failure in IgA Nephropathy
This infographic highlights the risk of progression to ESKD, including in patients traditionally considered low risk. Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
IgA Nephropathy
APRIL & the 4-Hit Pathogenic Cascade of IgAN
This infographic highlights the role of APRIL in a pre-hit 1 step that drives the 4-hit cascade.1 References 1. Mathur M, et al. J Clin Med. 2023;12(21):6927. Read MoreKey Messages from KDIGO IgAN Experts (2025)
These videos are part of a three-part series featuring IgA Nephropathy (IgAN) experts and Work Group Members of the forthcoming KDIGO 2025 IgAN Guideline Update sharing key insights on emerging… Read MoreFrom Diagnosis to Management in IgA Nephropathy: How Health Literacy Shapes the Patient Journey
Learn about health literacy and how it impacts patients with CKD including IgAN. Dr. Velez will share her expertise as a nephrologist treating patients with IgAN as well as discuss… Read MoreCooking Demo: Dietary Considerations for Patients with IgA Nephropathy
Registered Dietitian Lauren Levy and Kidney-Friendly Chef Anthony Valentine come together to bring their expertise in nutrition and IgAN, including discussing the basics of nutritional concepts – such as sodium… Read MoreUpdates in IgA Nephropathy
Learn the latest advancements in the understanding and management of IgA Nephropathy (IgAN) with two expert-led videos sponsored by Otsuka with Professors Brad Rovin, MD (United States) and Jürgen Floege,… Read MoreUnderstanding the Benefits & Risks of Corticosteroid Use in Patients With IgAN (Infographic)
This infographic highlights clinical trial results showing mixed efficacy and increased adverse events in patients with IgAN treated with corticosteroids. Read MoreOn-Demand Webinar: The Four-Hit Hypothesis & The Role Of APRIL In IgA Nephropathy
The goal of this on-demand webinar is to provide a detailed overview of the Four-Hit hypothesis as well as explain the role of APRIL in disease pathogenesis. Read MoreBreakdown of the MEST-C Score in IgA Nephropathy
This podcast provides an in-depth review of the Oxford MEST-C score, focusing on its practical application in diagnosing and prognosticating IgA Nephropathy. Read MoreRole of the Renal Pathologist in IgA Nephropathy
Through the lens of renal pathology, this webinar will provide insights into the histopathological features that are crucial for accurate diagnosis and risk stratification in IgA Nephropathy, highlighting the significance… Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
